HONG KONG, April 14, 2026 /PRNewswire/ -- Newmark announces the appointment of Roy Ng, MRICS, as Head of Research in Hong Kong, further strengthening the firm's research capabilities across the region.
In his role, Roy will lead market research, forecasting and thought leadership across office, industrial, retail and capital markets, supporting clients with data-driven insights amid evolving occupier and investment dynamics. He will work closely with Newmark's regional and global research teams to expand coverage, enhance analytical rigor and align local intelligence with global trends.
"Hong Kong represents one of the world's most complex and dynamic real estate markets," said Rhodri James, Vice Chairman in Hong Kong. "As capital flows, occupier strategies and policy dynamics continue to shift, rigorous, locally-grounded research is essential to unlocking opportunity. Roy's leadership strengthens our ability to help clients navigate the evolving landscape with clarity, conviction and a forward-looking view."
David Bitner, Executive Managing Director, Global Research, added, "As our research capabilities deepen across key global markets, we are creating exponential new opportunities for clients – connecting regional insight with global intelligence to drive better decisions, stronger outcomes and a more integrated understanding of real estate worldwide. Roy brings a rare combination of deep regional knowledge, technical research expertise and real-world advisory experience. He strengthens our ability to deliver timely, data-driven insights that help clients navigate complexity with confidence."
Roy brings more than a decade of experience across real estate research, leasing and strategic advisory roles, with a background spanning commercial leasing, capital markets analysis and regional research leadership. He has held senior roles across leading real estate firms, delivering market outlooks, forecasts and advisory insights for investors, developers and occupiers across Hong Kong and the Greater Pearl River Delta.
"Newmark's research is built around clarity, rigor and relevance for clients," said Roy. "I'm excited to deepen our insights across Hong Kong while connecting local intelligence with the global forces shaping occupier and investment decisions."
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries ("Newmark"), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark's comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform's global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the twelve months ended December 31, 2025, Newmark generated revenues of nearly $3.3 billion. As of December 31, 2025, Newmark and its business partners together operated from approximately 175 offices with over 9,300 professionals across four continents. To learn more, visit nmrk.com or follow @newmark.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company's business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Newmark Appoints Roy Ng as Head of Research in Hong Kong
Newmark Appoints Roy Ng as Head of Research in Hong Kong
|
WEST PALM BEACH, Fla., April 14, 2026 /PRNewswire/ -- As the global demand for medical travel, medical tourism, and healthcare tourism continues to accelerate, Global Healthcare Accreditation (GHA) remains at the forefront of advancing safe, transparent, and patient-centered cross-border care. Recognized as the first accreditation body dedicated exclusively to medical travel, GHA has played a pivotal role in shaping international standards, strengthening patient trust, and enabling healthcare providers and destinations worldwide to compete and collaborate in an increasingly globalized healthcare ecosystem.
Against this backdrop of rapid industry growth and transformation, GHA is pleased to announce the appointment of Dr. Jilan Liu as Vice President of Global Strategy, further strengthening its global leadership and strategic expansion across the Asia-Pacific region and beyond.
Dr. Liu brings more than three decades of international healthcare experience, extending to over 30 countries and multiple sectors including accreditation, consulting, health systems, and digital health transformation. She previously served as Chief Executive for Greater China at Healthcare Information and Management Systems Society, where she played an essential role in advancing the adoption of international health IT standards and accelerating digital transformation across hospitals in the region. In addition, as Principal Consultant and Director for Greater China at Joint Commission International, Dr. Liu advised hundreds of hospitals globally, guiding them in improving patient safety, operational excellence, and quality of care.
Dr. Liu's appointment reflects GHA's commitment to deepening its presence in the APAC region and supporting healthcare organizations in delivering high-quality, patient-centered, and globally aligned care. As Renée-Marie Stephano, CEO of Global Healthcare Accreditation, shared, "Jilan's extensive experience across accreditation, digital health, and healthcare transformation makes her uniquely positioned to guide our strategic growth in the APAC region and globally. Her leadership will be instrumental in strengthening our mission to improve patient safety, elevate standards, and support healthcare organizations navigating the evolving global healthcare landscape."
Reflecting on her new role, Dr. Liu noted, "I am honored to take on this role with Global Healthcare Accreditation at such a dynamic time for healthcare in the APAC region and beyond. There is a tremendous opportunity to align global standards with regional needs, strengthen trust, and support organizations in delivering high-quality, value-based, patient-centered care across borders. I look forward to contributing to GHA's continued growth and impact worldwide."
With Dr. Liu's leadership, GHA aims to further expand its footprint in Asia-Pacific and other strategic regions, foster strategic partnerships, and support healthcare providers to develop programs and operations in meeting the growing demand for safe, high-quality, and internationally trusted care.
About Global Healthcare Accreditation (GHA)
Global Healthcare Accreditation (GHA) goes beyond accreditation, serving as a strategic partner committed to enhancing patient experiences and promoting global healthcare practices. Drawing on expertise from leading accreditation bodies, healthcare innovators, and senior executives in the medical travel and wellness tourism sectors, GHA delivers tailored solutions for governments, healthcare providers, and industry stakeholders worldwide. Its Standards 5.0 for Medical Travel have been accredited by the International Society for Quality in Health Care External Evaluation Association (ISQua EEA), underscoring alignment with the highest international benchmarks for accreditation entities.
Through its accreditation, certification, training, and advisory services, GHA promotes transparency, patient-centered care, and continuous improvement across the global healthcare ecosystem.
WEST PALM BEACH, Fla., April 14, 2026 /PRNewswire/ -- As the global demand for medical travel, medical tourism, and healthcare tourism continues to accelerate, Global Healthcare Accreditation (GHA) remains at the forefront of advancing safe, transparent, and patient-centered cross-border care. Recognized as the first accreditation body dedicated exclusively to medical travel, GHA has played a pivotal role in shaping international standards, strengthening patient trust, and enabling healthcare providers and destinations worldwide to compete and collaborate in an increasingly globalized healthcare ecosystem.
Against this backdrop of rapid industry growth and transformation, GHA is pleased to announce the appointment of Dr. Jilan Liu as Vice President of Global Strategy, further strengthening its global leadership and strategic expansion across the Asia-Pacific region and beyond.
Dr. Liu brings more than three decades of international healthcare experience, extending to over 30 countries and multiple sectors including accreditation, consulting, health systems, and digital health transformation. She previously served as Chief Executive for Greater China at Healthcare Information and Management Systems Society, where she played an essential role in advancing the adoption of international health IT standards and accelerating digital transformation across hospitals in the region. In addition, as Principal Consultant and Director for Greater China at Joint Commission International, Dr. Liu advised hundreds of hospitals globally, guiding them in improving patient safety, operational excellence, and quality of care.
Dr. Liu's appointment reflects GHA's commitment to deepening its presence in the APAC region and supporting healthcare organizations in delivering high-quality, patient-centered, and globally aligned care. As Renée-Marie Stephano, CEO of Global Healthcare Accreditation, shared, "Jilan's extensive experience across accreditation, digital health, and healthcare transformation makes her uniquely positioned to guide our strategic growth in the APAC region and globally. Her leadership will be instrumental in strengthening our mission to improve patient safety, elevate standards, and support healthcare organizations navigating the evolving global healthcare landscape."
Reflecting on her new role, Dr. Liu noted, "I am honored to take on this role with Global Healthcare Accreditation at such a dynamic time for healthcare in the APAC region and beyond. There is a tremendous opportunity to align global standards with regional needs, strengthen trust, and support organizations in delivering high-quality, value-based, patient-centered care across borders. I look forward to contributing to GHA's continued growth and impact worldwide."
With Dr. Liu's leadership, GHA aims to further expand its footprint in Asia-Pacific and other strategic regions, foster strategic partnerships, and support healthcare providers to develop programs and operations in meeting the growing demand for safe, high-quality, and internationally trusted care.
About Global Healthcare Accreditation (GHA)
Global Healthcare Accreditation (GHA) goes beyond accreditation, serving as a strategic partner committed to enhancing patient experiences and promoting global healthcare practices. Drawing on expertise from leading accreditation bodies, healthcare innovators, and senior executives in the medical travel and wellness tourism sectors, GHA delivers tailored solutions for governments, healthcare providers, and industry stakeholders worldwide. Its Standards 5.0 for Medical Travel have been accredited by the International Society for Quality in Health Care External Evaluation Association (ISQua EEA), underscoring alignment with the highest international benchmarks for accreditation entities.
Through its accreditation, certification, training, and advisory services, GHA promotes transparency, patient-centered care, and continuous improvement across the global healthcare ecosystem.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Global Healthcare Accreditation Appoints Jilan Liu as Vice President of Global Strategy
